메뉴 건너뛰기




Volumn 28, Issue 2, 2009, Pages 379-385

Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccine (TIV) among persons ≥65 years old

Author keywords

Comparative immunogenicity; Immune responses; Immunization; Influenza vaccines; Recombinant hemagglutinin

Indexed keywords

FLUBLOK; INFLUENZA VACCINE; RECOMBINANT INFLUENZA HEMAGGLUTININ VACCINE; TRIVALENT INACTIVATED INFLUENZA VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

EID: 70649108630     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.10.037     Document Type: Article
Times cited : (46)

References (19)
  • 1
    • 0017854753 scopus 로고
    • Interpandemic influenza in the Houston area, 1974-76
    • Glezen W.P., and Couch R.B. Interpandemic influenza in the Houston area, 1974-76. N Engl J Med 298 (1978) 587-592
    • (1978) N Engl J Med , vol.298 , pp. 587-592
    • Glezen, W.P.1    Couch, R.B.2
  • 2
    • 0022527085 scopus 로고
    • Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78
    • Barker W.H. Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78. Am J Public Health 76 (1986) 761-765
    • (1986) Am J Public Health , vol.76 , pp. 761-765
    • Barker, W.H.1
  • 4
    • 0019183587 scopus 로고
    • Influenza vaccination of elderly persons. Reduction in pneumonia and influenza hospitalizations and deaths
    • Barker W.H., and Mullooly J.P. Influenza vaccination of elderly persons. Reduction in pneumonia and influenza hospitalizations and deaths. JAMA 244 (1980) 2547-2549
    • (1980) JAMA , vol.244 , pp. 2547-2549
    • Barker, W.H.1    Mullooly, J.P.2
  • 5
    • 0021981430 scopus 로고
    • Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during influenza A (H3N2) epidemic
    • Patriarca P.A., Weber J.A., Parker R.A., Hall W.N., Kendal A.P., Bregman D.J., et al. Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during influenza A (H3N2) epidemic. JAMA 253 (1985) 1136-1145
    • (1985) JAMA , vol.253 , pp. 1136-1145
    • Patriarca, P.A.1    Weber, J.A.2    Parker, R.A.3    Hall, W.N.4    Kendal, A.P.5    Bregman, D.J.6
  • 6
    • 0027973478 scopus 로고
    • The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial
    • Govaert T.M., Thijs C.T., Masurel N., Sprenger M.J., Dinant G.J., and Knottnerus J.A. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 272 (1994) 1661-1665
    • (1994) JAMA , vol.272 , pp. 1661-1665
    • Govaert, T.M.1    Thijs, C.T.2    Masurel, N.3    Sprenger, M.J.4    Dinant, G.J.5    Knottnerus, J.A.6
  • 7
    • 0037417219 scopus 로고    scopus 로고
    • Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly
    • Nichol K., Nordin J., Mullooly J., Lask R., Fillbrandt K., and Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. NEJM 348 (2003) 1322-1332
    • (2003) NEJM , vol.348 , pp. 1322-1332
    • Nichol, K.1    Nordin, J.2    Mullooly, J.3    Lask, R.4    Fillbrandt, K.5    Iwane, M.6
  • 8
    • 0037086692 scopus 로고    scopus 로고
    • A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community
    • Vu T., Farish S., Jenkins M., and Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 20 (2002) 1831-1836
    • (2002) Vaccine , vol.20 , pp. 1831-1836
    • Vu, T.1    Farish, S.2    Jenkins, M.3    Kelly, H.4
  • 10
    • 34548847744 scopus 로고    scopus 로고
    • Mortality benefits of influenza vaccination in elderly people: and ongoing controversy
    • Simonsen L., Taylor R.J., Viboud C., Miller M.A., and Jackson L.A. Mortality benefits of influenza vaccination in elderly people: and ongoing controversy. Lancet Infect Dis 7 (2007) 658-666
    • (2007) Lancet Infect Dis , vol.7 , pp. 658-666
    • Simonsen, L.1    Taylor, R.J.2    Viboud, C.3    Miller, M.A.4    Jackson, L.A.5
  • 11
    • 48949089658 scopus 로고    scopus 로고
    • Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices [ACIP]
    • Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 57 (2008) 1-60
    • (2008) MMWR , vol.57 , pp. 1-60
    • Centers for Disease Control and Prevention1
  • 12
    • 56949095843 scopus 로고    scopus 로고
    • New technologies for meeting the global demand for pandemic influenza vaccines
    • Fedson D.S. New technologies for meeting the global demand for pandemic influenza vaccines. Biologicals 36 (2008) 346-349
    • (2008) Biologicals , vol.36 , pp. 346-349
    • Fedson, D.S.1
  • 13
    • 32844456405 scopus 로고    scopus 로고
    • Expression and purification of an influenza hemagglutinin-one step closer to a recombinant protein-based influenza vaccine
    • Wang K., Holtz K.M., Anderson K., Chubet R., Mahmoud W., and Cox M.M. Expression and purification of an influenza hemagglutinin-one step closer to a recombinant protein-based influenza vaccine. Vaccine 24 (2006) 2176-2185
    • (2006) Vaccine , vol.24 , pp. 2176-2185
    • Wang, K.1    Holtz, K.M.2    Anderson, K.3    Chubet, R.4    Mahmoud, W.5    Cox, M.M.6
  • 14
    • 0029052912 scopus 로고
    • Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults
    • Powers D.C., Smith G.E., Anderson E.L., Kennedy D.J., Hackett C.S., Wilkinson B.E., et al. Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults. J Infect Dis 171 (1995) 1595-1599
    • (1995) J Infect Dis , vol.171 , pp. 1595-1599
    • Powers, D.C.1    Smith, G.E.2    Anderson, E.L.3    Kennedy, D.J.4    Hackett, C.S.5    Wilkinson, B.E.6
  • 15
    • 0029837041 scopus 로고    scopus 로고
    • Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults
    • Lakey D.L., Treanor J.J., Betts R.F., Smith G.E., Thompson J., Sannella E., et al. Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults. J Infect Dis 174 (1996) 838-841
    • (1996) J Infect Dis , vol.174 , pp. 838-841
    • Lakey, D.L.1    Treanor, J.J.2    Betts, R.F.3    Smith, G.E.4    Thompson, J.5    Sannella, E.6
  • 16
    • 33646067475 scopus 로고    scopus 로고
    • Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza virus hemagglutinin vaccine in elderly adults
    • Treanor J.J., Schiff G.M., Couch R.B., Cate T.R., Brady R.C., Hay C.M., et al. Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza virus hemagglutinin vaccine in elderly adults. J Infect Dis 193 (2006) 1223-1228
    • (2006) J Infect Dis , vol.193 , pp. 1223-1228
    • Treanor, J.J.1    Schiff, G.M.2    Couch, R.B.3    Cate, T.R.4    Brady, R.C.5    Hay, C.M.6
  • 17
    • 34247118878 scopus 로고    scopus 로고
    • Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine
    • Treanor J.J., Schiff G.M., Hayden F.G., Brady R.C., Hay C.M., Meyer A.L., et al. Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine. JAMA 297 (2007) 1577-1582
    • (2007) JAMA , vol.297 , pp. 1577-1582
    • Treanor, J.J.1    Schiff, G.M.2    Hayden, F.G.3    Brady, R.C.4    Hay, C.M.5    Meyer, A.L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.